HealthEquity, Inc. (NASDAQ:HQY) Receives $119.60 Average Price Target from Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY) have received an average rating of “Moderate Buy” from the seventeen brokerages that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating on the company. The average 1 year target price among brokers that have covered the stock in the last year is $119.60.

A number of analysts recently issued reports on the stock. Barrington Research reissued an “outperform” rating and set a $125.00 price target on shares of HealthEquity in a report on Thursday, December 4th. JPMorgan Chase & Co. upped their price objective on shares of HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research report on Thursday, December 4th. Citizens Jmp raised their target price on HealthEquity from $117.00 to $122.00 and gave the company a “market outperform” rating in a research report on Thursday, December 4th. KeyCorp lifted their price target on HealthEquity from $120.00 to $125.00 and gave the company an “overweight” rating in a research note on Thursday, January 8th. Finally, BMO Capital Markets reiterated a “market perform” rating on shares of HealthEquity in a research report on Thursday, December 4th.

HealthEquity Stock Performance

NASDAQ HQY opened at $73.88 on Monday. The firm has a market capitalization of $6.31 billion, a P/E ratio of 33.89, a PEG ratio of 0.91 and a beta of 0.24. The stock has a 50-day simple moving average of $88.39 and a two-hundred day simple moving average of $92.30. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. HealthEquity has a fifty-two week low of $72.90 and a fifty-two week high of $116.65.

HealthEquity (NASDAQ:HQY) last posted its earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, topping the consensus estimate of $0.90 by $0.11. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The firm had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. During the same period last year, the company earned $0.78 earnings per share. HealthEquity’s revenue for the quarter was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, equities analysts forecast that HealthEquity will post 2.32 earnings per share for the current year.

Insider Buying and Selling

In related news, EVP Elimelech Rosner sold 10,959 shares of HealthEquity stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the sale, the executive vice president owned 45,742 shares of the company’s stock, valued at approximately $4,366,073.90. This trade represents a 19.33% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction on Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the transaction, the executive vice president owned 73,979 shares of the company’s stock, valued at $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 13,959 shares of company stock worth $1,344,957 in the last quarter. Insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

A number of hedge funds have recently made changes to their positions in HQY. Sivia Capital Partners LLC purchased a new position in HealthEquity in the 2nd quarter valued at $306,000. US Bancorp DE increased its stake in HealthEquity by 10.9% during the second quarter. US Bancorp DE now owns 20,351 shares of the company’s stock worth $2,132,000 after acquiring an additional 2,001 shares during the last quarter. Vanguard Personalized Indexing Management LLC raised its position in HealthEquity by 27.0% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 10,639 shares of the company’s stock valued at $1,115,000 after purchasing an additional 2,263 shares during the period. Index Fund Advisors Inc. acquired a new position in shares of HealthEquity in the 2nd quarter valued at $246,000. Finally, Sequoia Financial Advisors LLC lifted its stake in shares of HealthEquity by 78.6% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 29,731 shares of the company’s stock valued at $3,115,000 after purchasing an additional 13,086 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.